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The bioactive lipid sphingosine-1-phosphate (S1P) is an important regulator in the
nervous system. Here, we explored the role of S1P and its receptors in vitro and
in preclinical models of peripheral nerve regeneration. Adult sensory neurons and
motor neuron-like cells were exposed to S1P in an in vitro assay, and virtually all
neurons responded with a rapid retraction of neurites and growth cone collapse
which were associated with RhoA and ROCK activation. The S1P1 receptor agonist
SEW2871 neither activated RhoA or neurite retraction, nor was S1P-induced neurite
retraction mitigated in S1P1-deficient neurons. Depletion of S1P3 receptors however
resulted in a dramatic inhibition of S1P-induced neurite retraction and was on the
contrary associated with a significant elongation of neuronal processes in response to
S1P. Opposing responses to S1P could be observed in the same neuron population,
where S1P could activate S1P1 receptors to stimulate elongation or S1P3 receptors and
retraction. S1P was, for the first time in sensory neurons, linked to the phosphorylation
of collapsin response-mediated protein-2 (CRMP2), which was inhibited by ROCK
inhibition. The improved sensory recovery after crush injury further supported the
relevance of a critical role for S1P and receptors in fine-tuning axonal outgrowth in
peripheral neurons.
Keywords: S1P, S1P3, neurite outgrowth, axonal regeneration, CRMP2, sensory neurons, neurite retraction, neurite
elongation
Abbreviations: ABC, ABC294640; CRMP2, collapsin response-mediated protein; dpl, days post-lesion; DRG, dorsal root
ganglia; GPCR, G-protein coupled receptor; n.b.c., neurite bearing cells; NF200, neurofilament 200; NGF, nerve growth
factor; PWL, paw withdrawal latency; ROCK, Rho kinase; S1P, sphingosine-1-phosphate; SphK1, sphingosine kinase
type 1; wt, wild-type.
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INTRODUCTION
Neuritogenesis is a complex event which involves a controlled
balance between elongation and retraction of neuronal processes
(da Silva and Dotti, 2002). The reorganization of the actin
cytoskeleton, which is regulated by the opposing actions of
the small GTPases Rho and Rac/Cdc42, is fundamental for
this fine balance (Li et al., 2002). Rac/Cdc42 are required
for the formation of lamellipodia or filopodia and thus
neurite extension (Estrach et al., 2002), whereas Rho
induces growth cone collapse and inhibition of neurite
outgrowth (Nakamura et al., 2002). The growth promoting
nerve growth factor (NGF) via its high affinity receptor
TrkA activates sphingosine kinase type 1 (SphK1; Edsall
et al., 1997), a kinase that phosphorylates sphingosine
to produce sphingosine-1-phosphate (S1P). S1P is an
important lipid mediator (Spiegel and Milstien, 2002)
and can bind five specific G protein-coupled receptors
(GPCRs), S1P1–S1P5. These receptors are enriched in the
nervous system and couple to different G proteins, Gi,
Gq and G12/13, to transmit diverse downstream signaling.
In particular, S1P1, S1P2 and S1P3 receptors are highly
expressed in sensory neurons (Zhang et al., 2006; Mair
et al., 2011; Kays et al., 2012; Camprubí-Robles et al., 2013;
Li et al., 2015) and differentially regulate Rac and Rho.
Signaling through S1P1 receptors enhances Rac-coupled
lamellipodia extension (Rosenfeldt et al., 2001a), whereas S1P2
or S1P3 receptors stimulate Rho and suppress Rac activity,
thereby inhibiting cell motility (Okamoto et al., 2000). In
neuronal cell lines S1P rapidly induces neurite retraction
and soma rounding with an EC50 as low as 1.5 nM, driven
by Rho-dependent remodeling of the actin cytoskeleton
(Postma et al., 1996). In contrast, the S1P1,3,4,5 receptor
ligand FTY720 (fingolimod) enhances neurite outgrowth
and alters growth cone morphology in primary cerebellar
neurons. In accordance, FTY720 stimulates axon regeneration
in mice after facial nerve axotomy through a signaling cascade
involving S1P receptors, G12/13 G-proteins, RhoA-GTPases
and the transcription factors SRF/MRTF (Anastasiadou and
Knöll, 2016). However, it has been recently suggested that
FTY720 rather acts as functional antagonist at S1P1,3,4,5
receptors (Hla and Brinkmann, 2011; Camm et al., 2014).
Both, neurite extension as well as retraction can result from
S1P action depending on the nature of S1P receptors that are
expressed.
Therefore, we set out to explore the importance of S1P in
peripheral nerve regeneration in a cellular model. Transgenic
mice with ablations of SphK1, S1P1 or S1P3 receptors were
used in combination with pharmacological tools. Together the
data of the present study point towards a critical importance
of S1P3 receptor for an overall deceleration of axonal growth,
inducing fast neurite retraction through activation of Rho
and Rho kinase (ROCK) and consequent phosphorylation
of the collapsin response-mediated protein-2 (CRMP2). In
accordance, S1P3 receptor ablation partially improved nerve




Experiments were performed according to National Austrian
legal requirements and the recommendations of the
IASP to minimize animal suffering (Zimmermann, 1983)
with permission of the Austrian Bundesministerium für
Wissenschaft, Forschung und Wirtschaft (BMWF-66.011/0102-
WF/V/3b/2015).
Mouse Strains and Surgical Procedure
Male wild-type (wt), S1P3−/−, SNS-S1P1−/− and S1P1fl/fl mice
(age between 8 and 12 weeks) were used in all experiments.
The mutated alleles were back crossed to C57BL/6J for at least
12 generations and littermates were used for controls (Mair et al.,
2011). Animals were housed on a 12 h light/dark cycle and had
free access to chow and water.
For induction of nerve crush injury mice were briefly
anesthesizsed with Ketasol (Graeub, Innsbruck, Austria) and
Xylasol (AniMedica) through intraperitoneal injection. After
cutaneous incision, the sciatic nerve was exposed and crushed
at mid-thigh level for 1 min by applying a standard force of
19 ± 1.8 N with a semi-electric feedback-controlled forceps as
previously published (modified Bioseb Rodent pincher RP-1,
Chaville Cedex, France; Quarta et al., 2014).
Behavioral Testing
Animals were maintained in individual cages for the entire
duration of the experimental paradigm of 15 days post lesion
(dpl). Following nerve lesion, heat sensitivity was quantified by
standard testing procedures (Andratsch et al., 2009; Quarta et al.,
2014). Measurements were performed two times before injury
and repeated at 1, 4, 8, 11, 15 dpl. Mice were allowed to habituate
for 1 h before testing. Heat sensitivity was assessed using the
Hargreaves test as previously published (Hargreaves et al., 1988),
where the withdrawal response latency to an increasing heat
stimulus (I.R. intensity = 51) was obtained with an automated
algesiometer (Ugo Basile, Comerio, Italy).
Culture of Primary Sensory Neurons
Adult mouse dorsal root ganglia (DRG) were dissected as
previously published (Obreja et al., 2002; Agarwal et al.,
2007). After dissection, ganglia were incubated in Liberase
Blendzyme 1 (9 mg/100 ml DMEM, Roche, Vienna, Austria)
for 60 min. After washing with PBS, 1× Trypsin-EDTA
(Invitrogen, Vienna, Austria) was added for 15min. Ganglia were
washed with supplemented TNBTM medium (Biochrom, Berlin,
Germany) containing L-glutamine (Invitrogen), streptomycin
sulfate (Invitrogen), penicillin G sodium and Protein-Lipid-
Komplex (Biochrom). The cell suspension obtained after
mechanical dissociation was centrifuged at 500 rpm through a
3.5% BSA gradient (Sigma Aldrich, Vienna, Austria) for 10 min
to remove cell debris. The pellet was resuspended in TNBTM
medium and centrifuged for 5 min at 760 rpm. The neurons were
plated on cover slips coated with poly-l-lysine (Sigma) and a top
layer of laminin (10 µg/ml, Sigma). Neurons were cultured in
TNBTM medium at 37◦C in a 5% CO2 atmosphere for 24 h.
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Live Imaging of Sensory Neuronal Cultures
After 20 h, culture dishes were transferred to Axio Imager
microscope (Carl Zeiss) with 20×, NA 0.30 objective. Images
were recorded in phase contrast with a cooled CCD camera
(SPOT; Diagnostic Instruments). Neurons were recorded at
room temperature (RT) for 60 min with or without S1P or
SEW2871 or FTY720-P at a concentration of 1 µM diluted in
extracellular solution (ECS). Images at 0, 30 and 60 min were
processed and compared as overlapped image for growth cone
collapse and neurite retraction signs using MetaMorph image
analysis (Meta Imaging Series 7.1, Version 7.1.6.0, Molecular
Devices). Neurons were counted as elongating or retracting, if
the majority of the neurites/neuron were respectively elongating
or retracting, or as no effect, if there was no change in
growth. For growth cone collapse assay, the distance between
the growth cone position at 0, 30 and 60 min was observed and
reported as difference. For inhibitor studies, neuronal cultures
were pre-incubated with nontoxic concentrations of the specific
inhibitor (C3-toxin) overnight or with Y27632 for 1 h before
time lapse recordings. Retracted neurons were counted in one
time-lapse recording frame before treatment and in the frame at
60 min after treatment. Control cultures were treated with equal
volumes of vehicle which did not affect survival or outgrowth.
During time lapse recording neurons were treated with 1µMS1P
for 60 min in the presence of the inhibitor.
Immunocytochemistry and Quantification
of Outgrowth of Sensory Neurons
Cells were fixed with 4% PFA for 20 min at RT. After
permeabilization with 0.01% TX-100 (Pierce, Vienna, Austria)
unspecific binding was blocked for 30 min with 10% normal
goat serum (Sigma) in PBS. Cells were incubated with the first
antibody (α-β-III-tubulin clone TuJ-1, 1:1000; R&D Systems,
Vienna, Austria) for 1 h, washed 3× for 10 min with PBS and
incubated with the appropriate secondary antibody for 30 min as
previously published (Quarta et al., 2014), counterstained with
4′,6-diamidino-2-phenylindole (DAPI; 1:10.000; Sigma) and
embedded in Mowiol (Calbiochem, Vienna, Austria). Secondary
antibodies used were chicken α-mouse Alexa Fluor 594 or
donkey α-mouse Alexa Fluor 488 (1:1000; Invitrogen) for
fluorescence microcopy.
Digitized images of randomly chosen areas of the coverslip
were taken using an Axio Imager microscope (Carl Zeiss) with
16×, NA 0.5 or 25×, NA 0.8 oil-immersion objective. Images
were recorded with a cooled CCD camera (SPOT; Diagnostic
Instruments). Experiments were performed in triplicates as
minimum requirement. Only neurons that were clearly separated
from neighboring cells were included for quantification. For
the analysis of the percentage of neurite bearing cells, neurons
with no visible process or with only filopodial formations were
counted as negative. Cells showing at least one neurite with a
total length of at least one cell diameter were counted as positive.
Quantification of the total length was performed as previously
(Quarta et al., 2014) using ImageJ software and NeuronJ plugin1
(Meijering et al., 2004).
1http://www.imagescience.org/meijering/software/neuronj/
Culture of Motor Neuron-Like Cells
Neuroblastoma x spinal cord motor neuron cells (NSC-34)
(kindly provided by Dr. Neil Cashman, University of Toronto,
ON, Canada), were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% foetal bovine serum
(FBS) and 1% penicillin/ streptomycin/glutamine solution (PSG)
as previously described (Cashman et al., 1992). Cells were
subcultured every 3–4 days. To slow the proliferation and
enhance the differentiation, cells were grown to 60% confluence
and the maintenance medium (DMEM, 10% FBS, 1% PSG)
was exchanged for differentiating medium (1:1 DMEM plus
Ham’s F12, 1% FBS, 1% PSG and 1% modified Eagle’s medium
non-essential amino acids, NEAA), as previously described by
Matusica et al. (2008). After 24–48 h culture, the medium was
replaced with fresh differentiating medium and the survived cells
were allowed to differentiate for up to∼7 days in the presence of
10 ng/ml BDNF and 1 ng/ml of CNTF. The media was refreshed
every 2 days (Matusica et al., 2008).
Live Imaging and Quantification of
Outgrowth of Motor Neuron-Like Cells
Motor neuron-like cells (NSC34) were cultured in 24-well glass
bottom plates coated with 0.015% poly-L-ornithine (Sigma)
and differentiated as described previously (Matusica et al.,
2008, 2016). Cells were seeded at a density of 3000 cells per
well, differentiated over 48 h as described above, and vehicle
or 1 µM of S1P (Sigma) was added to each well at the
initiation time of image capture. Neurite outgrowth assays were
performed on a FV1000 laser scanning confocal microscope
(Olympus) equipped with a 5.1% CO2 perfused and temperature
controlled (36.9◦C) environmental control chamber (Solent
Scientific). Image acquisition was performed on a 5 min interval
over a period of 90 min, not including plate temperature
calibration, using the multi-area time lapse (MATL) feature and
the DIC filters engaged for the transmitted light image and
0.5 µm 20× lens correction. Four fields of cells were randomly
imaged per well and analysis of neurite length and number of
neurites/neuronal cluster (cells contained within the field of view
with clearly identifiable processes) was performed on images
using the NeuronJ plugin (ImageJ). All subsequent analysis was
performed with Fiji (ImageJ) and Prism 7 (Graphpad, USA)
software.
Rho Activation Assay
Adult DRG neurons were cultured at a density of
2000 neurons/cm2 for 24 h and medium was replaced by
ECS for 3 h before the experimental procedure. Cultures were
treated for 10 min with S1P, FCS or SEW2871 as indicated.
RhoA-GTP pulldown assays were performed as described
previously (Schweigreiter et al., 2004). Briefly, neurons were
washed twice with ice-cold TBS and lysed with ice-cold lysis
buffer (500 µl; 50 mM Tris pH 7.2, 1% Triton X-100, 150 mM
NaCl, 10 mM MgCl2, plus protease inhibitors). Lysed cells
were scraped, collected into a pre-cooled Eppendorf tube and
centrifuged at 14,000 rpm at 4◦C for 5 min. The major part of
the supernatant (about 450 µl) was added to 18 µl Rhotekin
agarose beads (Millipore #14-383) and slowly rotated at 4◦C for
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50 min. A minor portion (50 µl) of the supernatant was used
for assessment of total RhoA amount. Beads were washed three
times with lysis buffer and elution and protein denaturation
was done with 1× Laemmli buffer at 95◦C for 5 min. Samples
were electrophoresed in 15% polyacrylamide and proteins were
transferred onto PVDF (polyvinylidene fluoride) membranes,
which were blocked in 1% skim milk solution and incubated
with anti-RhoA antibody (Santa Cruz #sc-418; 1:1000).
Western Blotting
Lumbar sensory neurons were harvested from 6 wt mice per
experiment and pooled for the following procedure. Sensory
neurons were cultured for 24 h and growth factor-deprived
in ECS (145 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, 10 mM D-Glucose; pH 7.3; Osm
305–308 mOsm/kg) before stimulation with S1P (1 µM) for
15, 30 and 60 min in the presence or not of the ROCK
inhibitor Y27632 (10 µM). A pre-treatment of 1 h with
Y27632 was performed. Non-treated cultures were used as
controls. Neurons were harvested in freshly prepared ice-cold
lysis buffer (50 mM Tris-HCl, 200 mMNaCl, 50 mMNaF, 1 mM
EDTA, 20 mM β-Glycerophosphate, 1% Triton X-100) enriched
with 1:30 phosphatase inhibitor complex (PIC, Sigma) and 1mM
phosphatase inhibitor sodium-ortho-vanadate (Sigma). Lysates
were processed as described previously (Quarta et al., 2014)
and protein content was measured with BCATM Protein Assay
kit (Thermo Scientific) according to the protocol. SDS-PAGE
was conducted under standard denaturing conditions and
25 µg of protein were loaded per lane. For immunodetection,
membranes were incubated with the specific antibodies diluted
according to the manufacture instructions. Blots were visualized
with enhanced chemiluminescence by using the SuperSignal
West Pico Chemiluminescent Substrate (Thermo Scientific)
and membranes scanned with LAS4000 luminescent imager
(GE Healthcare). Quantification was performed using ImageJ
software and relative values for phosphorylated proteins
are related to the non-phosphorylated form. α-phospho-
CRMP2 (Thr-555; 1:500; ECM Biosciences), α-CRMP2 (1:1000;
Cell Signaling) and α-tubulin (1:2000; Sigma) were used
as primary antibodies, and α-rabbit IgG (1:5000; Thermo
Scientific), α-mouse IgG (1:10,000; Sigma) secondary antibody
for detection.
In Situ Hybridization
The protocol was modified from an earlier method from
Obernosterer et al. (2007) and Camprubí-Robles et al. (2013).
Cryostat sections of mouse spinal cord were fixed with
4% PFA, digested with proteinase K (2 µg/ml in 50 mM
Tris buffer containing 5 mM EDTA), fixed again with 4%
PFA, acetylated (triethanolamine/HCl/acetic anhydride) and
incubated with prehybridization buffer (Roche). The S1P3 target
mRNA was hybridized with 0.34 pmol of specific antisense
double digoxigenin (DIG) labeled mRNA detection probes
(S1P3, 5DigN/ACTGATG AGGAAGGCGATGTAT/3Dig_N)
overnight at 55◦C (Camprubí-Robles et al., 2013). Scrambled
probes (Exiqon, Copenhagen, Denmark) served as negative
control. Washing with saline sodium citrate buffer (SSC) was
followed by blocking and incubation with alkaline phosphatase
coupled anti-DIG antiserum (1:5000, Roche) for 1 h, followed
by washing in levamisole buffer. Slides were incubated with
BCIP/NBT (Roche) to visualize S1p3 receptor mRNA, washed
in DEPC-treated water, coverslipped in buffered glycerol and
sealed. Images were taken using a brightfield microscope (BX50,
Olympus).
Isolation of Total RNA and Reverse
Transcription
Differentiated NSC-34 cells treated with vehicle (Control) and
S1P were harvested and stored in Trizol (Sigma) at −80◦C.
Samples were mechanically homogenized using a tissue lyser
(Qiagen). Total RNA was isolated using a column based
method (Zymo-Spin ICC Columns, Zymogen, Irvine, CA,
USA). DNA contamination was removed by on-column DNA
digestion. The concentration of total RNA was determined
using standard photospectrometry (Nanodrop 2000, Thermo
Scientific, Australia), quality of RNA was determined using a
lab-on-chip system (Bioanalyzer, Agilent). Only samples with
RNA integrity numbers (RIN) above seven were used for
subsequent analysis. One microgram of total RNA was reverse
transcribed into cDNA according to the manufacturer protocol
(SuperscriptII, BioRad, Australia).
qRT-PCR
Quantitative real-time polymerase chain reaction (qRT-PCR)
analysis of the relative mRNA expression levels of differentiated
NSC-34 cells treated with vehicle (Control) and S1P were
performed using the StepOnePlus cycler (Life Technologies).
TaqMan primers (Life Technologies) were used for the detection
of peptidergic and non-peptidergic markers and molecules
characteristic for mature nociceptive neurons. Hypoxanthine-
guanine phosphoribosyl transferase (HPRT) was used as a
reference gene. The efficiencies of all primer-pairs were
determined by 1/5 to 1/625 dilutions in a qPCR and a satisfying
efficiency was determined with Q-Gene (Simon, 2003). The
primers and efficiencies are listed in Table 1. The final volume
for qPCR was 20 µl of which 8 µl were H2O, 10 µl mastermix
(Life Technologies), 1 µl assay-mix (Life Technologies) and
1 µl cDNA. Each q-RT-PCR was done in duplicate. The Ct
values were determined for each product and normalized as
pairwise comparisons against the Ct value of the reference
gene. Subsequently the mean normalized expression (MNE) was
calculated and differences in the expression determined (Simon,
2003).
Compounds and Inhibitors
Factors used: 50 µM ABC294640 (Active Biochemicals Co.,
Limited; Hong Kong); 10 nM, 100 nM or 1 µM S1P (Sigma)
dissolved in 0.1% methanol. Inhibitors and agonists: 0.5 µg/ml
C3 toxin (Cytoskeleton, Inc.); 10 µM Y27632 (Calbiochem);
TABLE 1 | TaqMan primer assay.
Primer assay Assay code Amplicon length (bp) Efficiency (R2)
Hprt1 Rn1527840_m1 64 0.995
S1pr3 Mm02620181_s1 120 0.997
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10 µM SEW2871 (Calbiochem); 1 µM FTY720-P (Echeion
Biosciences).
Experimental Design and Statistical
Analysis
All experiments were performed in cell cultures/materials from
at least three different animals, and numbers of cells are reported
under each figure legend. Behavioral assays were performed in
10 or 11 male animals per genotype, as reported under the figure
legend. For statistical analysis the GraphPad software package
6 or 7 was used and data are presented as mean± SEM. Two-way
repeated measurements ANOVA followed by Tukey post hoc
test or Mann-Whitney U- post hoc test was used for multiple
comparisons between groups for behavioral assays. One-way
or two-way ANOVA followed by post hoc test was used for
multiple comparisons between groups for in vitro experiments.
Kruskal-Wallis test or Mann-Whitney U-test was calculated
for interindividual comparisons for in vitro experiments. Data
were analyzed by χ2-test for comparison of relative group sizes
for in vitro experiments. Individual test are reported under
each figure legends. Differences were considered statistically
significant at p< 0.05.
RESULTS
S1P Significantly Reduces Neurite
Outgrowth of Adult DRG Neurons in Vitro
The involvement of S1P in neuronal outgrowth was first studied
in short term cultures of adult DRG neurons as an in vitromodel
for peripheral nerve injury. Only 20% of adult DRG neurons
had visible processes when neurons were grown in culture for
24 h with 1 µM S1P compared to the 43% of neurons which
were treated with vehicle (Figures 1A,C; 42.88 ± 1.82% for ctrl
vs. 19.33 ± 4.93% for S1P-treated, p = 0.000391, χ2-test). At
the same time the total neurite length of neurons in S1P-treated
cultures was significantly reduced after 24 h of S1P treatment
(Figures 1A,B; 596.4 ± 41.48 µm for ctrl vs. 318.4 ± 35.28 µm
for S1P-treated, p < 0.001, U-test). S1P synthesis was previously
suggested to act downstream of the NOGO signaling pathway,
which has a significant anti-regenerative potential (Kempf et al.,
2014) and NGF signaling causes SphK1 translocation to the
plasma membrane with subsequent activation of the S1P1 and
S1P2 receptors (Toman et al., 2004). Thus, we first explored
whether SphKs, involved in S1P production, were involved in
the intrinsic extension of neuronal processes in adult sensory
neurons. Neuron cultures were obtained from mice with a global
null mutation of SphK1 (Sphk1−/−) and grown in the presence
or absence of the SphK2 inhibitor ABC294640 (ABC; Gao et al.,
2012). The inhibition of the activity of both SphK isoforms by
knock-out and ABC treatment for 24 h did not exhibit any
significant effect on neurite outgrowth (Figure 1D; p = 0.092,
Kruskal-Wallis test), indicating that inhibition of SphK activity
did not alter neurite outgrowth of sensory neurons in the absence
of exogenous S1P. Together, these results suggest that S1P might
serve a critical role in neurite outgrowth of sensory neurons,
FIGURE 1 | Sphingosine-1-phosphate (S1P) reduces neurite outgrowth of
adult dorsal root ganglia (DRG) neurons in vitro. (A) Representative examples
of DRG neuron cultures from wild-type (wt) mice under the effect of S1P. Scale
bar = 30 µm. Neurons were cultivated with or without S1P (1 µM) for 24 h and
stained with Tuj-1. (B) Neurite length of 24 h cultured wt neurons was
significantly decreased upon S1P treatment (596.4 ± 41.48 µm for ctrl vs.
318.4 ± 35.28 µm for S1P-treated, ∗∗∗p < 0.001, U-test; ctrl n = 209, S1P
n = 129). (C) The percentage of neurite bearing cells in treated cultures was
significantly reduced compared to untreated cultures (42.88 ± 1.82% for ctrl
vs. 19.33 ± 4.93% for S1P-treated, ∗∗∗p = 0.000391, χ2-test; ctrl n = 209,
S1P n = 129). (D) Treatment for 24 h with SphKs inhibitor ABC294640 (ABC)
did not induce any significant effect on the total neurite length of either wt or
Sphk1−/− DRG neurons (n.s., Kruskal-Wallis test, p = 0.092; 1071.03 ± 85.33
µm for wt ABC and 1235.60 ± 89.79 µm for Sphk1−/− ABC; wt vehicle
n = 337, ABC n = 291; Sphk1−/− vehicle n = 279, ABC n = 279).
in vitro, and that autocrine S1P signaling appears not to be
critically involved in the outgrowth of sensory neurons.
Dose and Time-Dependent S1P-Induced
Retraction of Adult DRG Neurons in Vitro
Since we and others have previously reported S1P effects to occur
on a fast time scale (Postma et al., 1996; Toman et al., 2004; Mair
et al., 2011; Camprubí-Robles et al., 2013), we explored whether
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S1P affected neurons with already existing neurites and applied
S1P for short durations to cultures in a live imaging set-up (15,
30, 60 and 90min). In wt neurons, S1P induced a time-dependent
retraction of neuronal processes which was visible after 15 min
(Figures 2A,B) and increased with prolonged S1P exposure
(Figure 2B). The percentage of neurons with retracting neurites
was significantly increased in a dose-dependent manner: 10 nM
S1P was already sufficient to induce a slight retraction, however
more neurons were elongating than retracting their neurites,
and nearly 80% of sensory neurons retracted their neurites in
response to 1 µM S1P (Figures 2A,C; p = 0.0001, χ2-test).
Similarly, the number of neurons which showed elongating
neurites was profoundly decreased to 11.8 ± 7.15% upon
1 µM S1P (Figure 2C). The retraction in response to 1 µM
S1P was accompanied by growth cone collapse visible at
higher magnification (Figures 2B,D). These results revealed
that physiologically relevant concentrations of S1P caused
fast retraction of already existing neurites of adult sensory
neurons.
S1P3 Receptor Is Involved in the
Retraction Adult DRG Neurons
Of the generally accepted five S1P receptors, S1P1, S1P2 and
S1P3 subtypes are expressed in DRG neurons (Zhang et al.,
2006; Mair et al., 2011; Camprubí-Robles et al., 2013). Out
of those three receptor subtypes, Toman et al. (2004) showed
that S1P1 receptor is involved in neurite extension, whereas
S1P2 and S1P3 receptors have been associated, respectively,
with processes retraction in PC12 cells (Toman et al., 2004)
and cell rounding (Van Brocklyn et al., 1999). We first used
SEW2871 to activate the S1P1 receptor, or FTY720-P, a ligand
at S1P1,3,4,5 receptors. In contrast to S1P, both, SEW2871 and
FTY720-P induced elongation of neurites (Figure 3A; p< 0.001,
U-test), and increased the number of neurons with elongating
neurites, rather than neurite retraction (Figure 3B; p < 0.001,
χ2-test). It should be noted that DRG neurons do not express
S1P4 or S1P5 and only a negligible fraction of neurons in our
culture conditions express S1P2 receptor subtype (Camprubí-
Robles et al., 2013). Since retraction was observed in more
than 80% of DRG neurons upon 1 µM S1P, we hypothesized
that S1P-induced neurite retraction could be mediated through
activation of S1P3 receptors. To prove this hypothesis, DRG
neuronal cultures from transgenic mouse lines with global or
sensory neuron specific deletions of S1P receptors were exposed
to S1P. In cultures from adult S1P3−/− mice, the average total
neurite length was significantly increased in the presence of S1P
after 24 h (426.5 ± 69.32 µm vs. 825.4 ± 158.8 µm; p = 0.0432,
U-test; Figure 3C). Moreover, in S1P3−/− primary DRG cultures,
the percentage of neurons that responded to S1P after 60 min
with a retraction was significantly reduced compared to wt
(74.49± 5.89% vs. 38.74± 4.98%; p< 0.001, χ2-test; Figure 3D).
In contrast, a conditional, sensory neuron specific deletion
of the S1P1 receptor subtype (SNS-S1P1−/−) did not produce
a significant change in the percentage of retracted neurons
compared to control cultures (Figure 3D). SNS-S1P1−/− mice
lack S1P1 mRNA expression and immunoreactivity specifically
in DRG neurons (Mair et al., 2011). Sensory neuron cultures
from SNS-S1P1−/− mice showed reduced elongation upon S1P
treatment, however, upon exposure to FTY720-P we observed a
FIGURE 2 | Dose and time-dependent S1P-induced retraction of adult DRG neurons in vitro. (A) Representative example of wt adult sensory neurons at 0, 30 and
60 min after S1P and the retractive effect on already existing neurites. Scale bar = 30 µm. (B) Growth cones of adult wt DRG neurons retracted within 15 min upon
1 µM S1P treatment. The distance covered by retracting growth cones was significantly higher at 90 min compared to 15 min (p = 0.0014, one-way ANOVA
followed by Tukey post hoc test; n = 41). (C) S1P elicited a retractive effect in a dose-dependent manner, with nearly 80% of cells retracting and the number of
elongating neurons decreasing after 1 µM S1P (p = 0.0001, χ2-test; vehicle n = 35, S1P 10 nM n = 65; 100 nM n = 65; 1 µM n = 30). (D) Representative example at
higher magnification of growth cone collapse after S1P treatment. Scale bar 10 µm. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
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FIGURE 3 | S1P3 receptor is involved in neurite retraction while S1P1 in
elongation of adult DRG neurons. (A) S1P receptor agonists SEW2871, which
activates S1P1, and FTY720-P, agonist for S1P1,3,4,5, produced a different
effect compared to S1P. SEW2871 increased significantly the total neurite
length, which was decreased in presence of S1P compared to untreated 24 h
DRG cultures (∗∗∗p < 0.001, U-test; ctrl n = 209, S1P n = 129, SEW2871
n = 124, FTY720-P n = 138). (B) The percentage of retracted neurons was
significantly decreased upon 60 min SEW2871 or FTY720-P treatment
compared to S1P-treated cultures (∗∗∗p < 0.001, χ2-test; ctrl n = 27, S1P
n = 76, SEW2871 n = 104, FTY720-P n = 87). (C) Adult sensory neurons from
mice with global deletion of S1P3 receptor (S1P3−\−) showed a significant
increase in total neurite length after 24 h S1P treatment (∗p = 0.0432, U-test;
ctrl n = 150, S1P n = 100). (D) 60 min of S1P treatment on already existing
neurites exhibited a significant decrease in the number of retracted neurons in
S1P3−\− DRG cultures (∗∗∗p < 0.001, χ2-test), in contrast, SNS-S1P1−\−
neurons showed similar effect to S1P of wt neurons (n.s., χ2-test; wt n = 76,
S1P1fl/fl n = 31, SNS-S1P1−\− n = 110, S1P3−\− n = 191). (E) Adult sensory
neuron cultures from SNS-S1P1−\− mice showed reduced retraction and
enhanced elongation upon FTY720-P treatment (∗∗∗∗p < 0.0001, χ2-test; S1P
n = 155, FTY720-P n = 71).
significant increase in the elongation compared to S1P treated
cultures (Figure 3E; p < 0.0001, χ2-test). This puzzling result
could be explained with the recently reported antagonistic effect
of FTY720-P at S1P receptors (Hla and Brinkmann, 2011; Camm
et al., 2014) and possible inhibition at S1P3 receptor subtype,
since sensory neurons in culture express mainly S1P1 and S1P3
receptors, as mentioned above.
These observations support the concept that S1P binding
to S1P3 receptor acts to facilitate neurite retraction of primary
sensory neurons. In contrast, activation of S1P1 receptor may
rather promote neurite elongation.
S1P Induces Retraction via Rho/ROCK
Activation and CRMP2 Phosphorylation
S1P3 receptor activates members of the Rho GTPase family
(Pyne and Pyne, 2000a,b; Sanchez and Hla, 2004; Obinata
and Hla, 2012) which are known regulators of axon growth
and neuronal morphogenesis (Fujita and Yamashita, 2014). We
therefore performed pull-down assays and observed that S1P
treatment of primary DRG neuron cultures activated RhoA
within 10 min in a dose-dependent manner (Figures 4A,E).
Furthermore, S1P-induced neurite retraction was significantly
reduced in vitro by the specific Rho inhibitor C3-toxin
(Figure 4B; retracted p = 0.0005, two sample t-test). In
addition, the percentage of neurons responding to S1P with an
elongation of neurites increased significantly in the presence
of C3-toxin (Figure 4B; elongated p < 0.001, two sample
t-test). The same effect was observed with the ROCK inhibitor
Y27632, which decreased the percentage of retracted neurons
to nearly 30% compared to S1P-treated cultures (Figure 4C;
p < 0.001, χ2-test). In contrast, the S1P1 receptor selective
agonist SEW2871 did not activate RhoA even at high doses
(Figures 4D,E), which is in line with the findings obtained
in S1P1 deficient neurons. Since the effect of S1P on neurite
retraction occurred within the first 15 min, we investigated the
ROCK-dependent phosphorylation of one of its downstream
targets, the CRMP2. CRMP2 binds to tubulin dimers and
enhances microtubule formation (Fukata et al., 2002), however
phosphorylation at threonine-555 by ROCK, reduces its ability
to bind tubulin, leading to microtubule disorganization and
growth cone collapse (Arimura et al., 2000, 2005). We assessed
phospho-CRMP2 (pCRMP2) levels before and after 15, 30 and
60 min of S1P treatment in primary DRG neuron cultures
from adult wt mice. Western blot analysis revealed that
S1P induced rapid phosphorylation of CRMP2 at Thr-555,
with a 2.6-fold increase at 30 min (Figures 4F,G; ctrl vs.
S1P 15’ p = 0.019, ctrl vs. S1P 30’ p < 0.0001, ctrl vs.
S1P 60’ p = 0.027, one-way ANOVA followed by Tukey
post hoc test), while total CRMP2 expression was unchanged
(Figure 4H, p = 0.2478, one-way ANOVA with multiple
comparisons correction). Notably, addition of the ROCK
inhibitor, Y27632, inhibited S1P-induced phosphorylation of
CRMP2 (Figures 4F,G; p < 0.0001, one-way ANOVA followed
by Tukey post hoc test). Altogether, these results support
the hypothesis that S1P is a critical inducer of neurite
retraction in adult sensory neurons through S1P3 receptor by
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FIGURE 4 | S1P induces retraction via Rho/ROCK activation and collapsin response-mediated protein-2 (CRMP2) phosphorylation. (A) RhoA activation was
observed in a pull-down assay upon 10 min S1P treatment of adult DRG neurons cultured for 24 h. (B) C3-toxin, which inhibited Rho activation, reversed the
S1P-dependent retraction decreasing the number of retracted neurons compared to S1P only -treated cultures (S1P vs. S1P + C3 retracted p = 0.0005, elongated
p < 0.001, two sample t-test between percents; vehicle n = 77, S1P n = 108, S1P + C3 n = 106). Cultures were pre-treated overnight with C3-toxin and then
treated with 1 µM S1P for 60 min in the presence of the toxin. (C) Treatment with Y27632 compound reversed the retraction effect of 1 µM S1P (p < 0.001, χ2-test;
vehicle n = 27, S1P n = 76, S1P + Y27632 n = 134). Cultures were pre-treated for 1 h with Y27632 before S1P stimulation. (D) Different concentrations of
SEW2871 after 10 min stimulation did not activate downstream RhoA in adult sensory neuronal cultures. (E) Quantification of RhoA levels obtained from cultures
before and after 1 µM SEW2871 or 1 µM S1P treatment (ctrl vs. SEW2871, n.s. p = 0.5172; ctrl vs. S1P, ∗p = 0.019, Kruskal-Wallis test followed by Dunn’s post
hoc test; n = 3). (F) Representative western blot for phospho-CRMP2 (pCRMP2 Thr-555) levels in wt DRG neuronal cultures before and after 15’, 30’ and 60’ S1P
treatment (1 µM). (G) Quantification of pCRMP2 levels vs. CRMP2 obtained from treated and untreated cultures. Levels of total CRMP2 were similar in all samples.
pCRMP2 levels increased significantly upon S1P stimulation, with a peak of CRMP2 phosphorylation/inactivity at 30 min (∗∗∗∗p < 0.0001, one-way ANOVA followed
by Tukey post hoc test; n = 3, ctrl vs. S1P 15’ p = 0.019, ctrl vs. S1P 30’ p < 0.0001, ctrl vs. S1P 60’ p = 0.027). These levels were significantly reduced, thus
CRMP2 phosphorylation was reversed, upon Y27632 inhibitor (S1P 30’ vs. Y27632 + S1P 30’ p < 0.0001). (H) Total CRMP2 levels were similar in all samples and
not significantly different compared to tubulin (p = 0.2478, one-way ANOVA; n = 3). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001.
activating the downstream Rho/ROCK pathway with subsequent
ROCK-dependent CRMP2 phosphorylation.
S1P Produces Retraction of Motor
Neuron-Like Cells in Vitro
S1P3 receptor mRNA is expressed in populations of small- and
large-diameter DRG sensory neurons as we previously observed
(Camprubí-Robles et al., 2013). Since in situ hybridization of
the spinal cord demonstrated the presence of S1P3 receptor
mRNA also in motor neurons in the ventral spinal horn
(Figure 5A), we investigated whether S1P could affect neuronal
outgrowth of motor neurons as for sensory neurons.We cultured
motor neuron-like cells for 24 h and exposed them to S1P
in a time-lapse experiment. Akin to sensory neurons, motor
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FIGURE 5 | S1P produces retraction of motor neuron-like cells in vitro. (A) In situ hybridization (ISH) experiments in mouse spinal cord sections showed that
S1P3 receptor mRNA was expressed in motor neurons. Detection of the S1P3 antisense probe showed clear intracellular but not nuclear staining in somata of motor
neurons and smaller neurons in the ventral horn. No staining could be detected in the scrambled probe control. Scale bar 100 µm. (B) Motor neuron-like cultures
were treated with 1 µM S1P for 60 min and observed in a time-lapse experiment. Scale bar 100 µm. (C) The number of neurites per neuronal cluster (cells contained
within the field of view with clearly identifiable processes) was significantly reduced after S1P stimulation (one-way ANOVA, Bonferroni post hoc test; vehicle n = 8,
S1P n = 8). (D) After 15 min of S1P also the total neurite length was reduced compared to the vehicle (p < 0.001, two-way ANOVA; Tukey post hoc test; vehicle
n = 8, S1P n = 8). (E) Relative S1P3 receptor subtype mRNA expression quantified by qRT-PCR. The target mRNA expression is normalized to endogene expression
and amplification efficiency. The mean normalized expression (MNE) for vehicle and S1P treated samples is represented. The S1P3 receptor MNE did not differ after
S1P treatment (Mann-Whitney test, P = 1.000; n = 3). ∗∗p < 0.01, ∗∗∗p < 0.001.
neuron-like cells started to retract already after 15 min of
S1P stimulation, and severely retracted neurites after 30 min
(Figure 5B). At 1 µM, S1P treatment significantly reduced
the number of neurites per neuronal cluster (Figure 5C;
0 vs. 15 min p = 0.0039; 0 vs. 30 min p < 0.0001;
0 vs. 60 min p < 0.0001, one-way ANOVA, Bonferroni
post hoc test) and the mean neurite length (Figure 5D;
0 vs. 15 min p = 0.0049; 0 vs. 30 min p < 0.0001; 0 vs.
60 min p < 0.0001, one-way ANOVA, Tukey post hoc test)
after 30 min stimulation. After 30 min S1P-treated cells had
8 neurites/neuronal cluster compared to 17 neurites/neuronal
cluster of the vehicle treated cells. Moreover, S1P treatment
decreased the total neurite length of motor neuron-like cells
from 79.258 ± 4.202 µm to 59.101 ± 4.192 µm after
30 min (Figure 5D). In line with our ex vivo data, motor
neuron-like cells significantly expressed S1P3 receptor subtype
and the normalized mRNA expression did not change after S1P
treatment (Figure 5E). Therefore, our data indicate that S1P
affects neuronal morphology not only in adult sensory neurons
but as well in motor neurons which likewise express the S1P3
receptor, indicating a wider action of S1P in functionally different
neuron types.
S1P3 Receptor Is Involved in Recovery of
Sensory and Motor Function after
Peripheral Nerve Injury in Vitro
To demonstrate the relevance of S1P3 receptor signaling
in peripheral nerve regeneration in vivo, we used a sciatic
nerve crush injury model and monitored sensory thresholds
as signature of the functional recovery 15 days post-lesion
(dpl). S1P3−\− mice recovered significantly faster to normal
heat paw withdrawal latencies after crush injury compared
to wt control group (Figure 6A; day 4 p = 0.016, day 8
p = 0.045, two way RM ANOVA, Mann-Whitney post hoc
test with Holm-Bonferroni’s multiple correction): in both wt
Frontiers in Molecular Neuroscience | www.frontiersin.org 9 October 2017 | Volume 10 | Article 317
Quarta et al. S1P and S1P3 Receptor in Neuronal Retraction
FIGURE 6 | S1P3 receptor is involved in recovery of sensory and motor
function after peripheral nerve injury in vivo. (A) S1P3−/− animals (black
square) underwent sciatic nerve crush and compared to a control group (wt,
open square) for sensory thresholds. Already 4 days post-lesion (dpl) S1P3−\−
mice recovered heat paw withdrawal latencies in comparison to wt animals
(174 ± 11% for wt vs. 133 ± 10% for S1P3−\−; day 4 p = 0.016, two way RM
ANOVA, Mann-Whitney post hoc test with Holm-Bonferroni’s multiple
correction; n = 10). In wt mice sensitivity returned to baseline only at 15 dpl
(day 1 206 ± 17% for wt vs. 181 ± 15% for S1P3−\−; day 15 125 ± 18% for
wt vs. 103 ± 12% for S1P3−\−), while in S1P3−\− animals the recovery was
significantly improved from early stages post-lesion (day 1 181 ± 15%; day 4
133 ± 10%; day 8 132 ± 11%, day 8 p = 0.045). (B) SNS-S1P1−/− mice did
not show any significant difference in recovery of heat paw withdrawal
thresholds compared to control S1P1fl/fl mice (two way RM ANOVA, genotype:
F(1,131) = 0.371, p = 0.549; time points: F(6,131) = 16.599, p < 0.001;
genotype × time points: F(6,131) = 0.602, p = 0.728; n = 11). ∗p < 0.05.
and S1P3−\− mice heat sensitivity decreased after injury,
however remained elevated in wt mice and returned to
baseline at 15 dpl (day 1: 206 ± 17% vs. 181 ± 15%, and
day 15: 125 ± 18% vs. 103 ± 12% for wt and S1P3−\−,
respectively). In S1P3−\− animals the heat sensitivity was
significantly improved already from early post-lesion stages (day
1: 181 ± 15%; day 4: 133 ± 10% and day 8: 132 ± 11%).
In line with our in vitro data, sensory recovery of conditional
knock-out animals for S1P1 receptor was comparable to wt,
indicating that the S1P1 receptor is not critically involved
in the recovery after peripheral lesion (Figure 6B; two way
RM ANOVA, genotype: F(1,131) = 0.371, p = 0.549; time
points: F(6,131) = 16.599, p < 0.001; genotype × time points:
F(6,131) = 0.602, p = 0.728). These in vivo data together with
our in vitro results introduce S1P3 receptor signaling as a
general regulator of the outgrowth of peripheral neurons, which
appears to be important in the fine-tuning of peripheral nerve
regeneration and degeneration.
DISCUSSION
During neurogenesis, neuronal migration and axonal growth
several factors, such as growth factors or chemokines, serve
as chemoattractant to guide the neuronal processes towards
their target (da Silva and Dotti, 2002). Previous reports
have associated S1P with nervous system development and
neurogenesis (Brinkmann, 2007; Proia and Hla, 2015). However,
the biological function of S1P in the adult nervous system is not
fully understood.
In the present study we have explored the role of S1P
in axonal outgrowth. We provide in vitro and in vivo
evidence that S1P via S1P3 receptors and RhoA/ROCK
signaling module induced neurite retraction of adult sensory
and motor neuron-like cells which may represent one
of the factors hampering neuron regeneration following
injury. Moreover, we suggest that S1P-induced neurite
retraction might be associated with CRMP2 phosphorylation
at threonine-555, which was abolished by ROCK
inhibition.
We found that addition of exogenous S1P to the culture
medium overnight reduced the number of adult sensory
neurons with neurites and their total neurite length in vitro,
whereas depletion of sphingosine kinase 1 (Sphk1) or
pharmacological inhibition of both SphK isoforms 1 and
2 with the ABC294640 inhibitor, to prevent endogenous S1P
generation, did not affect the above parameters. This suggests
that endogenous neuronal S1P production was not sufficient
to account for the observed growth inhibition by S1P, whose
role in nerve regeneration is still controversial. Surprisingly, the
neurotrophin nerve growth factor NGF, which has a growth
promoting activity, causes translocation of SphK1 to the plasma
membrane and activation of S1P1 and S1P2 receptors (Toman
et al., 2004). However, S1P also suppresses the NGF-induced
neurite extension (Toman et al., 2004) and on Xenopus retinal
cells S1P elicits growth cone collapse and repulsive axonal
responses (Strochlic et al., 2008).
In view of this dual role of S1P, we studied the effect of S1P
on existing neurites. S1P application not only decreased the total
neurite length in short-term DRG cultures, but also induced a
pronounced retraction of neurites and a collapse of adult sensory
neuron growth cones within 30 min.
Since not only sensory but also motor neuron-like cells
responded to S1P with a reduction in the number and total
length of neurites, it is anticipated that S1P may play a
general role in fine-tuning neuronal morphology and axonal
outgrowth.
Importantly, S1P-induced retraction was noticeable at 10 nM
and saturated at 1µMS1P. These concentrations are comparable
to those found in the plasma (1 µM) and in the lymph (100 nM),
and even lower concentrations are measurable in the interstitial
fluid of tissues (Proia and Hla, 2015). InDrosophila phosphatidic
acid phosphatases are involved in generating an extracellular S1P
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gradient (Zhang et al., 1997) and, in mammals, this S1P gradient
regulates cell migration in blood and lymphatic circulatory
system (Hla et al., 2008; Aoki et al., 2016). Thus, a possible
S1P gradient between the nervous system and the target tissue
may be effective to guide growing axons during development or
regeneration to correctly polarize and find their targets.
S1P receptors are widely expressed in the nervous system,
with S1P1 presumably being the most predominant subtype.
Adult mouse sensory neurons express the S1P receptor subtypes
S1P1, S1P2 and S1P3 (Mair et al., 2011; Wang et al., 2015):
S1P1 receptors are expressed in the nociceptor population, S1P2
receptors in the proprioceptive neurons and S1P3 receptors
are present virtually in all neurons in the DRG (Mair et al.,
2011; Camprubí-Robles et al., 2013). S1P1 activation controls
cytoskeletal rearrangements and cell motility and enhances
cortical actin formation (Rosenfeldt et al., 2001a,b). In line
with these reports, we observed that the S1P1 receptor agonist
rather accelerated neurite outgrowth in short-term adult DRG
cultures. The S1P2 receptor subtype is involved in cell rounding
and neurite retraction in PC12 cells (Toman et al., 2004) and
S1P3 stimulates cell migration and membrane ruffling in CHO
cells (Okamoto et al., 2000). Although S1P2 receptors may be
associated with anti-regenerative responses uponNOGObinding
(Kempf et al., 2014) and be responsible for growth cone collapse
in retinal cells (Strochlic et al., 2008), only a negligible fraction
of DRG neurons expresses S1P2 receptors (Camprubí-Robles
et al., 2013), whereas 80% of neurons responded to S1P retracting
their neurites. We, for the first time to our knowledge, provide
evidence that the retraction induced by S1P was dramatically
reduced in S1P3 receptor deficient sensory neurons, pointing to
an important role of S1P3 receptors. Support for this finding
comes from different cell lines where S1P3 receptor subtype
promotes membrane ruffling (Okamoto et al., 2000) and affects
cell morphology (Van Brocklyn et al., 1999). These observations
have been reported from cell lines, which, however, do not
always resemble a neuronal phenotype. S1P binds S1P1 and S1P3
receptor subtypes with a different affinity (S1P1: Kd = 8–20 nM;
S1P3: Kd = 23–26 nM; Kluk and Hla, 2002; Watters et al.,
2011), thus, under physiological conditions supporting axon
regeneration after injury, the growth-promoting effect of S1P1
receptors might overrule the growth-inhibiting effect of S1P3
receptors due to these differences in receptor affinity. Moreover,
our data suggest that different concentrations of S1P released at
the injury site might fine-tune the growth response during the
different phases of axonal regeneration depending on whether
S1P1 or S1P3 receptors are more active. Both growth-promoting
and growth-inhibitory factors are released at the injury site
during regeneration, as neurotrophic factors, pro-inflammatory
and anti-inflammatory cytokines, generating a highly regulated
environment to permit regeneration (Gaudet et al., 2011). The
finding that S1P still induced neurite retraction in 40% of
neurons lacking S1P3 receptors indicates a broader scenario
and a possible redundancy of the system. Our results on
FTY720-P support this complexity and the fine-activation of
S1P receptors. FTY720-P is a ligand at S1P1,3,4,5 receptors
and stimulates axon regeneration after axotomy (Anastasiadou
and Knöll, 2016). In sensory neuronal cultures, we observed
that FTY720-P induced elongation of neurites rather than
retraction like S1P, most likely due to FTY720 activation of
S1P1 receptors. On the other hand, DRG neurons lacking S1P1
receptors showed reduced retraction and enhanced elongation
compared to S1P treated neurons. This paradoxical effect
could be explained by an antagonistic action at S1P3 receptors
(Hla and Brinkmann, 2011; Camm et al., 2014). Together,
these studies point towards a critical role of S1P signaling in
the refined regulation of neuron regeneration, and possibly
differentiation, in a cooperative and controlled manner. The
fine-tuning between extension and retraction of axons represents
an important process during neuroregeneration and synapse
formation.
Individual S1P receptors activate different downstream
signaling pathways depending on the G proteins which they
are coupled with. S1P1 receptors are associated with Gi/o and
activate Rac to promote migration and vasodilatation, whereas
S1P2 and S1P3 receptors can couple to Gq and G12/13 to
activate Rho and ROCK and inhibit cell migration and induce
vasoconstriction (Okamoto et al., 2000; Brinkmann, 2007). In
DRG neuron cultures, RhoA and ROCK were activated upon
stimulation with the same S1P dose that promoted retraction,
and retraction was abolished by inhibition of RhoA with
C3 toxin, while the S1P1 receptor agonist did not activate
RhoA. Therefore, we explored the involvement of further RhoA
effectors. CRMP2 is a member of the collapsin response-
mediated protein (CRMP) family and a known target of ROCK
phosphorylation (Arimura et al., 2000, 2005). It plays a crucial
role in embryonic development, neuronal polarity, in particular
in neurite elongation, and is required for axon formation (Wang
and Strittmatter, 1996; Inagaki et al., 2001; Arimura et al.,
2004). CRMP2 binds to tubulin heterodimers and promotes
microtubule assembly. Phosphorylation of CRMP2 inhibits
this activity and causes cytoskeleton destabilization (Fukata
et al., 2002). A RhoA/ROCK-dependent phosphorylation of
CRMP2 at threonine-555 (Thr-555) inactivates CRMP2 and
mediates growth cone collapse in DRG neurons (Arimura et al.,
2000, 2005). CRMP2 has a prominent role in nerve regeneration
after nerve injury (Suzuki et al., 2003) and appears to be involved
in Guillain Barrè pathogenesis, where auto-antibodies inhibit
neurite outgrowth and axon regeneration in vivo and elicit
growth cone collapse upon RhoA/ROCK pathway activation
and subsequent CRMP2 phosphorylation at Thr-555 (Rozés
Salvador et al., 2016). Moreover, motor neurons overexpressing
CRMP2 exhibit accelerating reprojection (Suzuki et al., 2003)
and inhibition of CRMP2 phosphorylation by cdk5 and GSK3,
on sites T509/T514/S518/S522, in a spinal cord injury model
results in improved locomotive and nociceptive recovery (Nagai
et al., 2016). Our data link ROCK activation by S1P to
CRMP2 phosphorylation at Thr-555 for the first time to our
knowledge in sensory neurons. CRMP2 phosphorylation was
significantly abolished by blocking ROCK activity. S1P binding
to S1P3 receptors led to retraction of sensory and motor
neuron-like cells, and we provide evidence that support the
involvement of RhoA/ROCK axis and CRMP2 S1P-dependent
phosphorylation in the outgrowth regulation of adult peripheral
neurons.
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We provide evidence for the relevance of S1P3 receptor
subtype in S1P-dependent neurite retraction through a
transgenic mouse model with a global deletion of S1P3, which
exhibited improved sensory recovery after nerve crush injury.
No such compensation was observed in mice with a sensory
neuron specific null mutation of the S1P1 receptor subtype.
Based on our present results and previous reports S1P appears
to play an important dual role in orchestrating the axonal growth
in peripheral neurons, by activation of S1P1 receptors for growth-
promoting responses and of S1P3 receptors for growth inhibition
and retraction. Our findings raise the possibility that agonists at
the diverse S1P receptors may qualify as promising therapeutic
strategies for neurological disorders and neurodegenerative
diseases associated with anomalous regenerative responses.
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